APA-referens (7:e uppl.)

Gu, X., Lu, S., Xu, S., Li, Y., Fan, M., Lin, G., . . . Zhang, X. (2025). Novel oral compound Z526 mitigates cancer-associated cachexia via intervening NF-κB signaling and oxidative stress. Genes and Diseases, 12(2), . https://doi.org/10.1016/j.gendis.2024.101292

Chicago-referens (17:e uppl.)

Gu, Xiaofan, et al. "Novel Oral Compound Z526 Mitigates Cancer-associated Cachexia via Intervening NF-κB Signaling and Oxidative Stress." Genes and Diseases 12, no. 2 (2025). https://doi.org/10.1016/j.gendis.2024.101292.

MLA-referens (9:e uppl.)

Gu, Xiaofan, et al. "Novel Oral Compound Z526 Mitigates Cancer-associated Cachexia via Intervening NF-κB Signaling and Oxidative Stress." Genes and Diseases, vol. 12, no. 2, 2025, https://doi.org/10.1016/j.gendis.2024.101292.